BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Corporate Distress Financial Stress SEC Filings β€” February 17, 2026

USA Corporate Distress & Bankruptcy

55 high priority55 total filings analysed

Executive Summary

Across 55 8-K filings on 2026-02-18 in the USA Corporate Distress & Bankruptcy stream, a dominant theme is undisclosed material definitive agreements (Item 1.01 in 40+ filings, e.g., Cannabist, urban-gro, Core Scientific), likely distress financings or restructurings amid liquidity pressures. Critical bearish signals include 1 explicit bankruptcy/receivership (Granite Construction, Item 1.03), 5 delisting notices (Bubblr, CIMG, Outlook Therapeutics, Chain Bridge I, Nuburu; Item 3.01), and frequent new financial obligations (Item 2.03 in 15+ filings like Gladstone, Energy Vault, ARKO) plus unregistered equity sales (Item 3.02 in 5 filings like urban-gro, Granite) signaling dilution and debt reliance. No period-over-period comparisons, quantitative metrics, insider trading, forward-looking guidance, or capital allocation details disclosed across any filing, highlighting opacity in distress situations and potential for further downside. Mixed/neutral sentiment prevails (90%+), but bearish outliers elevate portfolio risk; sector patterns show small-cap biotechs/energy/REITs hit hardest. Implications: Heightened bankruptcy risk cluster, avoid longs, monitor for Chapter 11 waves.

Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from February 16, 2026.

Investment Signals(12)

  • Bankruptcy/receivership (Item 1.03) + material agreement + equity sales (Items 1.01/3.02) signals imminent restructuring, no offsetting positives

  • β–²

    Notice of delisting/failure to meet listing standards (Item 3.01), pure negative event with no metrics or mitigation

  • β–²

    Delisting notice (Item 3.01) + Reg FD disclosure (Item 7.01), indicates compliance failure and distress opacity

  • Delisting risk (Item 3.01), biotech sector vulnerability with no financial details to counter

  • β–²

    Critical delisting/failure to satisfy listing rules (Item 3.01), potential OTC downgrade

  • β–²

    Multi-signal distress with delisting (Item 3.01), rights modifications (Item 3.03), governance changes (Item 5.03) + material agreement

  • Repeated material agreements + unregistered equity sales (Item 3.02), dilution risk in agrotech

  • Material agreement + financial obligation + equity sales (Items 1.01/2.03/3.02), energy storage liquidity crunch

  • β–²

    Financial obligation + equity sales (Items 2.03/3.02) atop material agreement, biotech dilution pattern

  • β–²

    Material agreement + leadership departures (Items 1.01/5.02), potential mgmt instability in crypto mining

  • β–²

    Material agreement + direct financial obligation (Items 1.01/2.03), healthcare services debt spike

  • β–²

    Financial obligation + other events (Items 2.03/8.01), real estate distress financing

Risk Flags(10)

Opportunities(8)

Sector Themes(6)

  • Delisting Wave in Small Caps
    β—†

    5/55 filings (9%) with Item 3.01 (Bubblr, CIMG, Outlook biotech, Chain Bridge SPAC, Nuburu), signals broad compliance failures, liquidity traps; avoid small-cap longs

  • Financing Frenzy via Debt/Equity
    β—†

    15+ Item 2.03 financial obligations (e.g., Gladstone BDC, Energy Vault energy, ARKO retail) + 5 Item 3.02 dilutions, 40%+ filings indicate cash crunches, rising leverage across sectors

  • Material Agreements Ubiquity
    β—†

    40+/55 (73%) Item 1.01, undisclosed terms likely restructurings in biotech/energy/REITs (Theriva, Gran Tierra, CareTrust), opacity favors shorts

  • Leadership Instability Clusters
    β—†

    Item 5.02 in 5 filings (Core Scientific, Marchex, SAFE & GREEN), correlates with distress filings, mgmt turnover as early warning

  • Governance Tweaks in Distress
    β—†

    Item 3.03 rights mods in 3 (Western Digital tech, Jaguar health, Nuburu), + Item 5.03 in Nuburu, erodes shareholder value amid troubles

  • REIT/Construction Epicenter
    β—†

    CareTrust/RLJ/SmartStop REITs + Granite bankruptcy, property/infra sectors vulnerable to rate/distress cycles

Watch List(8)

Filing Analyses(55)
Cannabist Co Holdings Inc.8-Kneutralmateriality 9/10

18-02-2026

Cannabist Co Holdings Inc. filed a Form 8-K on 2026-02-18 (AccNo: 0001776738-26-000004, size 131 KB) reporting under Item 1.01 its entry into a material definitive agreement. No details on the agreement's parties, terms, value, strategic rationale, or financial implications are disclosed. No quantitative metrics, positive or negative performance indicators, or forward-looking guidance are provided.

  • Β·AccNo: 0001776738-26-000004
  • Β·Event date aligns with filing date: 2026-02-18
GLADSTONE INVESTMENT CORPORATION\DE8-Kneutralmateriality 8/10

18-02-2026

Gladstone Investment Corporation filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 reporting the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

urban-gro, Inc.8-Kneutralmateriality 8/10

18-02-2026

urban-gro, Inc. filed a Form 8-K on 2026-02-18 reporting entry into a Material Definitive Agreement under Item 1.01, Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, counterparties, financial terms, or impacts provided. No revenue, earnings, balance sheet effects, guidance changes, or other quantitative metrics are disclosed.

  • Β·File size: 1 MB
  • Β·Accession Number: 0001213900-26-017587
  • Β·Sector: NOT_DISCLOSED
Core Scientific, Inc./tx8-Kneutralmateriality 8/10

18-02-2026

Core Scientific, Inc. filed a Form 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, with Item 9.01 providing financial statements and exhibits. No quantitative metrics, transaction details, personnel names, dollar values, or performance comparisons (positive, negative, or flat) are disclosed. This is a multi-item filing focused on material events without specified financial impacts.

WESTERN DIGITAL CORP8-Kneutralmateriality 7/10

18-02-2026

Western Digital Corp filed a Form 8-K on 2026-02-18 under Item 3.03, disclosing material modifications to the rights of security holders. No specific details on the nature of the modifications, dollar values, financial impacts, or strategic rationale are provided. This requires review of the full filing for complete assessment.

CareTrust REIT, Inc.8-Kneutralmateriality 8/10

18-02-2026

CareTrust REIT, Inc. filed a Form 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details regarding the agreement's parties, terms, dollar value, strategic rationale, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics, period-over-period comparisons, or forward-looking guidance provided.

  • Β·Accession Number: 0001140361-26-005889
  • Β·Filing size: 845 KB
urban-gro, Inc.8-K/Amixedmateriality 8/10

18-02-2026

urban-gro, Inc. filed an 8-K on 2026-02-18 reporting under Item 1.01 its entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, indicating potential strategic or financing activity. However, no details on transaction size, terms, parties, financial impact, or dilution effects are disclosed. This multi-item filing is informational without quantified metrics.

  • Β·AccNo: 0001213900-26-017595
  • Β·File size: 203 KB
urban-gro, Inc.8-K/Aneutralmateriality 7/10

18-02-2026

urban-gro, Inc. filed an 8-K on 2026-02-18 (AccNo: 0001213900-26-017516) disclosing under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No details on the agreement's parties, terms, value, financial impacts, or strategic context are disclosed.

Bubblr Inc.8-Kbearishmateriality 10/10

18-02-2026

Bubblr Inc. filed a Form 8-K on 2026-02-18 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, dollar amounts, percentages, or other quantitative data disclosed. This represents a material negative event with no offsetting positive disclosures.

Energy Vault Holdings, Inc.8-Kneutralmateriality 8/10

18-02-2026

Energy Vault Holdings, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001104659-26-016759), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, financial impacts, or strategic context provided in the summary. No positive or negative metrics, period-over-period changes, or guidance revisions are disclosed.

IMAC Holdings, Inc.8-Kneutralmateriality 7/10

18-02-2026

IMAC Holdings, Inc. filed an 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

GRANITE CONSTRUCTION INC8-Kbearishmateriality 10/10

18-02-2026

Granite Construction Inc filed an 8-K on February 18, 2026 (AccNo: 0000861459-26-000006), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 1.03 (Bankruptcy or Receivership), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses a core bankruptcy-related event with no specific financial metrics, transaction values, or quantitative impacts provided. No positive metrics were mentioned, highlighting severe financial distress.

Mister Car Wash, Inc.8-Kneutralmateriality 7/10

18-02-2026

Mister Car Wash, Inc. filed a multi-item Form 8-K on February 18, 2026, disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation), Item 5.02 (Departure of Directors or Certain Officers; Election or Appointment), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, period-over-period comparisons, or other quantitative data are disclosed in the provided filing summary. This appears to be a comprehensive voluntary and mandatory disclosure covering operational results, agreements, and governance matters.

CREATIVE REALITIES, INC.8-Kneutralmateriality 8/10

18-02-2026

CREATIVE REALITIES, INC. filed an 8-K on February 18, 2026 (AccNo: 0001437749-26-004453), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

BREAD FINANCIAL HOLDINGS, INC.8-Kneutralmateriality 7/10

18-02-2026

Bread Financial Holdings, Inc. filed an 8-K on 2026-02-18 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 1.02 Termination of a Material Definitive Agreement. No financial details, transaction values, or impacts are disclosed. No quantitative metrics or period-over-period comparisons are provided.

i-80 Gold Corp.8-Kneutralmateriality 8/10

18-02-2026

i-80 Gold Corp. filed a Form 8-K on February 18, 2026, reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. Specific details regarding the nature of the agreement, disclosures, events, transaction values, financial impacts, or any quantitative metrics are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

Theriva Biologics, Inc.8-Kneutralmateriality 8/10

18-02-2026

Theriva Biologics, Inc. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. This is a multi-item mandatory and voluntary filing, but no details on the agreement's nature, parties, value, or financial impacts are provided in the available information. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

  • Β·AccNo: 0001104659-26-016792
  • Β·Filing size: 677 KB
LIXTE BIOTECHNOLOGY HOLDINGS, INC.8-Kneutralmateriality 9/10

18-02-2026

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed a Form 8-K on 2026-02-18 disclosing entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement's nature, parties, terms, financial impacts, or quantitative metrics provided. No performance metrics, positive or negative changes, or period-over-period comparisons were mentioned.

La Rosa Holdings Corp.8-Kneutralmateriality 8/10

18-02-2026

La Rosa Holdings Corp. filed a Form 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed. This multi-item filing signals material developments but lacks quantitative context for assessment.

Stardust Power Inc.8-Kneutralmateriality 8/10

18-02-2026

Stardust Power Inc. filed a multi-item Form 8-K on February 18, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and Regulation FD disclosure (Item 7.01), with exhibits under Item 9.01. No specific details on the agreement, transaction size, strategic rationale, or financial impacts are disclosed. The filing appears timely as it was submitted on the event date.

Jaguar Health, Inc.8-Kneutralmateriality 6/10

18-02-2026

Jaguar Health, Inc. filed a Form 8-K on February 18, 2026, reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the modifications, disclosures, events, or exhibits provided in the summary. No financial metrics, transactions, or performance data are disclosed.

WEALTHFRONT CORP8-Kneutralmateriality 8/10

18-02-2026

Wealthfront Corp filed an 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, financial impact, or strategic rationale are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

GRANITE CONSTRUCTION INC8-K/Amixedmateriality 8/10

18-02-2026

Granite Construction Inc filed a Form 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01 alongside termination of another material definitive agreement under Item 1.02, while also disclosing unregistered sales of equity securities under Item 3.02. Item 9.01 provides financial statements and exhibits. No transaction values, financial impacts, or strategic details disclosed.

Unknown8-Kneutralmateriality 8/10

18-02-2026

The company filed a Form 8-K on February 18, 2026, disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details regarding the agreement's terms, parties, financial impacts, or strategic rationale are provided in the filing summary. This represents a multi-item filing focused on a significant contractual event.

Unknown8-Kneutralmateriality 8/10

18-02-2026

The company filed an 8-K on February 18, 2026 (AccNo: 0001104659-26-016992), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, financial impacts, or metrics are disclosed in the provided information. This is an informational filing signaling a potentially significant event, but lacking quantification.

Mondelez International, Inc.8-Kneutralmateriality 7/10

18-02-2026

Mondelez International, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001628280-26-009018), reporting multiple material events under Item 1.01 (entry into a material definitive agreement), Item 1.02 (termination of a material definitive agreement), Item 2.03 (creation of a direct financial obligation or off-balance sheet arrangement), and Item 9.01 (financial statements and exhibits). No quantitative details such as transaction values, financial impacts, or period-over-period comparisons are disclosed. This multi-item filing indicates significant contractual changes, but lacks specifics on nature, size, or strategic implications.

Origin Materials, Inc.8-Kneutralmateriality 3/10

18-02-2026

Origin Materials, Inc. filed an 8-K on February 18, 2026, specifically under Item 5.07 disclosing Submission of Matters to a Vote of Security Holders. This is a standard informational filing reporting outcomes of a shareholder vote, with no financial metrics, vote results, or other quantitative data provided. No positive or negative performance indicators are mentioned.

FLYEXCLUSIVE INC.8-Kneutralmateriality 8/10

18-02-2026

flyExclusive Inc. filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

T1 Energy Inc.8-Kneutralmateriality 9/10

18-02-2026

T1 Energy Inc. filed an 8-K on 2026-02-18 reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, financial terms, or impacts are disclosed. Filing accession number 0001213900-26-017944, size 257 KB.

  • Β·File size: 257 KB
  • Β·Accession Number: 0001213900-26-017944
MARCHEX INC8-Kneutralmateriality 8/10

18-02-2026

Marchex Inc filed an 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the agreement, transaction terms, personnel involved, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing with no mentioned positive or negative financial metrics.

SM Energy Co8-Kneutralmateriality 8/10

18-02-2026

SM Energy Co filed an 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing with no specifics on dollar values, strategic implications, or market effects.

CIMG Inc.8-Kbearishmateriality 10/10

18-02-2026

CIMG Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001493152-26-007338), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific reasons for the delisting, financial impacts, dollar values, or other quantitative details are disclosed.

ETSY INC8-Kneutralmateriality 8/10

18-02-2026

Etsy Inc filed a multi-item 8-K on February 18, 2026, reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, period-over-period comparisons, or other quantitative data are disclosed in the provided filing summary. This appears to be a combined disclosure of a strategic agreement and financial results without further elaboration.

Array Technologies, Inc.8-Kneutralmateriality 8/10

18-02-2026

Array Technologies, Inc. filed a Form 8-K on February 18, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, financial impacts, or performance metrics (positive, negative, or flat) are disclosed.

INTEGRATED BIOPHARMA INC8-Kneutralmateriality 8/10

18-02-2026

INTEGRATED BIOPHARMA INC filed an 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01. Item 9.01 discloses financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are provided.

ZYNEX INC8-Kneutralmateriality 8/10

18-02-2026

Zynex Inc filed an 8-K on 2026-02-18 (AccNo: 0001104659-26-017102, Size: 836 KB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, financial impacts, or metrics provided in the summary. No positive or negative financial metrics, period-over-period comparisons, or guidance changes were disclosed.

ITT INC.8-Kneutralmateriality 9/10

18-02-2026

ITT Inc. filed an 8-K on February 18, 2026 (AccNo: 0000216228-26-000018), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are disclosed.

GRAN TIERRA ENERGY INC.8-Kmixedmateriality 8/10

18-02-2026

Gran Tierra Energy Inc. filed a multi-item 8-K on February 18, 2026, reporting entry into a new material definitive agreement (Item 1.01) while terminating a prior material definitive agreement (Item 1.02), alongside the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Although the termination may relieve prior commitments, the new agreement and financial obligation introduce unknown balance sheet impacts. Item 9.01 provides financial statements and exhibits, but no transaction values, terms, or quantitative metrics were disclosed.

Sky Harbour Group Corp8-Kneutralmateriality 8/10

18-02-2026

Sky Harbour Group Corp filed an 8-K on 2026-02-18 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 provides Financial Statements and Exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are disclosed.

LanzaTech Global, Inc.8-Kneutralmateriality 8/10

18-02-2026

LanzaTech Global, Inc. filed an 8-K on 2026-02-18 (AccNo: 0001628280-26-009171, Size: 199 KB) disclosing under Item 1.01 entry into a Material Definitive Agreement. No details on the agreement's nature, parties, dollar value, financial impacts, or strategic context were provided. This appears to be a single-item mandatory filing with sector not specified.

RLJ Lodging Trust8-Kneutralmateriality 8/10

18-02-2026

RLJ Lodging Trust filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 2.03 announcing the creation of a direct financial obligation or off-balance sheet arrangement. Item 8.01 reports other events, while Item 9.01 lists financial statements and exhibits. No specific transaction details, financial metrics, or impacts were disclosed.

Unknown8-Kneutralmateriality 8/10

18-02-2026

The company filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-057378), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the material definitive agreement, other events, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or scheduled events are mentioned.

ARKO Corp.8-Kneutralmateriality 8/10

18-02-2026

ARKO Corp. filed an 8-K on 2026-02-18 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing, but specific details on the agreement, transaction terms, financial impacts, or dollar values are NOT_DISCLOSED. No quantitative metrics, guidance changes, or scheduled events were provided.

Outlook Therapeutics, Inc.8-Kbearishmateriality 10/10

18-02-2026

Outlook Therapeutics, Inc. filed an 8-K on 2026-02-18 under Item 3.01, announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, impacts, or related events were disclosed.

Avalon GloboCare Corp.8-Kmixedmateriality 8/10

18-02-2026

Avalon GloboCare Corp. filed an 8-K on February 18, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 listing Financial Statements and Exhibits. While the material definitive agreement may indicate strategic developments, the financial obligation and unregistered equity sales could imply increased leverage or shareholder dilution. No specific transaction details, dollar values, terms, or financial metrics are disclosed.

Chain Bridge I8-Kbearishmateriality 10/10

18-02-2026

Chain Bridge I filed a Form 8-K on February 18, 2026 (AccNo: 0001213900-26-018000), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This event indicates potential removal from US exchange listing with no additional financial metrics, impacts, or reasons disclosed. Sector not specified.

ARKO Petroleum Corp.8-Kneutralmateriality 7/10

18-02-2026

ARKO Petroleum Corp. filed an 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative metrics, dollar values, period-over-period changes, or specific transaction details are provided.

OneMeta Inc.8-Kneutralmateriality 8/10

18-02-2026

OneMeta Inc. filed a Form 8-K on 2026-02-18 reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are provided.

CNX Resources Corp8-Kneutralmateriality 8/10

18-02-2026

CNX Resources Corp filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-057453), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. Specific details of the material agreement, disclosures, transaction value, financial impacts, or any metrics are NOT_DISCLOSED in the provided filing summary. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

  • Β·Multi-item 8-K filing including mandatory Item 1.01 for material definitive agreement
SmartStop Self Storage REIT, Inc.8-Kneutralmateriality 8/10

18-02-2026

SmartStop Self Storage REIT, Inc. filed a Form 8-K on 2026-02-18 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative details such as transaction value, financial impacts, or specific terms are disclosed.

Liminatus Pharma, Inc.8-Kneutralmateriality 9/10

18-02-2026

Liminatus Pharma, Inc. filed a Form 8-K on February 18, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific details regarding the agreement, events, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. This is a multi-item mandatory disclosure for Item 1.01 with potential voluntary elements in Item 8.01.

  • Β·Accession Number: 0001104659-26-017134
  • Β·Filing size: 942 KB
  • Β·Multi-item 8-K (Items 1.01, 8.01, 9.01)
Nuburu, Inc.8-Kbearishmateriality 9/10

18-02-2026

Nuburu, Inc. filed a multi-item Form 8-K on February 18, 2026, disclosing entry into a material definitive agreement (Item 1.01), notice of delisting or failure to satisfy a continued listing rule or standard (Item 3.01), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). The inclusion of Item 3.01 signals potential delisting risks, which is negative for liquidity and valuation, while Item 1.01 indicates an undisclosed material agreement whose impact is unknown. No quantitative financial metrics, transaction values, or specific details are provided.

SAFE & GREEN HOLDINGS CORP.8-Kneutralmateriality 8/10

18-02-2026

SAFE & GREEN HOLDINGS CORP. filed a Form 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, personnel names, dollar values, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary.

JFB Construction Holdings8-Kneutralmateriality 8/10

18-02-2026

JFB Construction Holdings filed a multi-item Form 8-K on February 18, 2026, reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, transaction values, financial impacts, personnel names, or quantitative metrics are disclosed in the provided filing summary. This mandatory disclosure signals potentially significant developments but lacks substance for directional assessment.

RESEARCH FRONTIERS INC8-Kneutralmateriality 7/10

18-02-2026

RESEARCH FRONTIERS INC filed an 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or performance metrics are provided.

Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 55 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Corporate Distress Financial Stress SEC Filings β€” February 17, 2026 | Gunpowder Blog